ziyad al aly glp 1 Al-Aly, MD on X: "GLP-1 drugs are associated with a 35% higher risk of NAION, an eye condition that can cause sudden vision loss. About 6 to 10 extra cases per GLP-1 drugs carry wide variety

Interestingly, GSTO1 was identified as one of the potential cellular targets of piperlongumine, an electrophilic compound exerting selective cytotoxicity against cancer cells through an oxidative cell death mechanism (Supplementary Table 25) 37

His publications help contextualize method-centered review of complex peptide and protein materials, including analytical testing, batch records, and verification and validation

Indication Insights Why Did the Type 2 Diabetes Mellitus Segment Lead the GLP-1 Market in 2025

Sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis

Neuropeptide Y increases force development through a mechanism that involves calcium entry in resistance arteries